S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Critical asset just had biggest fall on record (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Critical asset just had biggest fall on record (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Critical asset just had biggest fall on record (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
Warren Buffett uses his annual letter to warn about Wall Street and recount Berkshire's successes
Critical asset just had biggest fall on record (Ad)
MarketBeat Week in Review – 2/19 - 2/23
A collection of the insights Warren Buffett offered in his annual letter Saturday
Critical asset just had biggest fall on record (Ad)
West Africa bloc lifts coup sanctions on Niger in a new push for dialogue to resolve tensions
West Africa's ECOWAS bloc says it's lifting sanctions imposed on Niger over last year’s coup in a new push for dialogue
AI Creates New Cancer Drug - In Just 30 Days! (Ad)
Macron booed by French farmers who blame him for not doing enough to support agriculture
MILAN FASHION PHOTOS: Ferragamo, Dolce&Gabbana conceal and reveal, balance transparency with cover
OTCMKTS:EKTAY

Elekta AB (publ) (EKTAY) Stock Price, News & Analysis

$7.22
-0.04 (-0.55%)
(As of 02/23/2024 ET)
Today's Range
$7.17
$7.33
50-Day Range
$6.99
$8.35
52-Week Range
$6.52
$8.65
Volume
6,002 shs
Average Volume
6,387 shs
Market Capitalization
$2.77 billion
P/E Ratio
21.86
Dividend Yield
2.08%
Price Target
N/A

Elekta AB (publ) MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
0.71mentions of Elekta AB (publ) in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
14.63%
From $0.41 to $0.47 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.74 out of 5 stars


EKTAY stock logo

About Elekta AB (publ) Stock (OTCMKTS:EKTAY)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

EKTAY Stock Price History

EKTAY Stock News Headlines

Elekta AB (publ) goes ex dividend Monday
Elon Musk's "Project Dojo" is a Game-Changer
Morgan Stanley predicts that Musk's latest act will boost Tesla's shares by 80% in the next 12 months. But if you want to profit from this development, you'll buy the firm that could see its sales explode by 829% as "Project Dojo" sweeps the nation.
Is Elekta (EKTAY) Stock Undervalued Right Now?
Is Elekta (EKTAY) a Great Value Stock Right Now?
Elekta AB ADR EKTAY
The Retirement of Your Dreams Awaits You…
Imagine it's 2025 and you have the financial freedom to pursue any of your biggest goals. All of this because YOU decided to take action in 2024. The Bitcoin Halving in 2024 could change your life forever...And the strategies outlined in the Crypto Retirement Blueprint will give you what you need to be able to crush the upcoming halving cycle bull run, and potentially retire quickly in wealth.
Elekta AB Series B
Elekta AB (publ) (EKTAY)
Elekta AB (publ) (EKTA-B.ST)
ELEKTA B SHS ADR (OTC: EKTAY)
Elekta AB (publ)
Elekta (EKTAY) Presents at ESTRO 2022
Elekta: Interim report, May-January 2021/22
New finance chief at Elekta
See More Headlines
Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/30/2023
Today
2/24/2024
Ex-Dividend for 3/18 Dividend
2/26/2024
Dividend Payable
3/18/2024
Fiscal Year End
4/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
OTCMKTS:EKTAY
Employees
4,540
Year Founded
N/A

Profitability

Net Income
$90.25 million
Pretax Margin
8.25%

Debt

Sales & Book Value

Annual Sales
$1.61 billion
Cash Flow
$0.56 per share
Book Value
$2.43 per share

Miscellaneous

Free Float
225,231,000
Market Cap
$2.77 billion
Optionable
Not Optionable
Beta
1.16
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Laurent Leksell (Age 72)
    Founder & Chairman
    Comp: $1.64M
  • Mr. Gustaf Salford (Age 47)
    President & CEO
    Comp: $14.62M
  • Mr. Tobias Hagglov (Age 46)
    Chief Financial Officer
  • Cecilia Ketels
    Head of Investor Relations
  • Mr. Jonas Bolander (Age 58)
    Executive VP of Group Functions, Secretary & General Counsel
  • Mr. Mattias Thorsson
    VP and Head of Corporate Communications & Public Affairs
  • Ms. Anna Conneryd Lundgren (Age 39)
    Executive VP & Chief People Officer
  • Mr. John Lapré (Age 60)
    President of Brachy & Neuro Solutions
  • Mr. Maurits Wolleswinkel (Age 53)
    President of Linac & Software Solutions
  • Mr. Habib Nehme (Age 60)
    Chief Commercial Officer














EKTAY Stock Analysis - Frequently Asked Questions

Should I buy or sell Elekta AB (publ) stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elekta AB (publ) in the last year. There are currently 2 sell ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "reduce" EKTAY shares.
View EKTAY analyst ratings
or view top-rated stocks.

How have EKTAY shares performed in 2024?

Elekta AB (publ)'s stock was trading at $8.1495 at the start of the year. Since then, EKTAY stock has decreased by 11.5% and is now trading at $7.2150.
View the best growth stocks for 2024 here
.

How were Elekta AB (publ)'s earnings last quarter?

Elekta AB (publ) (OTCMKTS:EKTAY) released its earnings results on Thursday, November, 30th. The company reported $0.09 earnings per share for the quarter. The business earned $430.83 million during the quarter. Elekta AB (publ) had a trailing twelve-month return on equity of 15.19% and a net margin of 7.47%.

How often does Elekta AB (publ) pay dividends? What is the dividend yield for Elekta AB (publ)?

Elekta AB (publ) declared a dividend on Tuesday, January 30th. Shareholders of record on Tuesday, February 27th will be paid a dividend of $0.1146 per share on Monday, March 18th. The ex-dividend date of this dividend is Monday, February 26th.
Read our dividend analysis for EKTAY
.

Is Elekta AB (publ) a good dividend stock?

Elekta AB (publ) (OTCMKTS:EKTAY) pays an annual dividend of $0.15 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 45.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EKTAY will have a dividend payout ratio of 31.91% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EKTAY.

How do I buy shares of Elekta AB (publ)?

Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EKTAY) was last updated on 2/25/2024 by MarketBeat.com Staff